Project title
利用Vorinostat與第三代酪胺酸激酶抑制劑聯合治療肺腺癌EGFR 點突變C797所造成的抗藥性( I )
Internal ID
MOST108-2314-B002-195
Principal Investigator
Start Date
August 1, 2019
End Date
July 31, 2020
Organizations
Partner Organizations
Vorinostat Combined with Third Generation Tkis to Overcome Egfr C797 Mutation in Lung Adenocarcinoma (I)
Keywords
表皮生長因子受體(EGFR)
抗藥性
C797S點突變
聯合治療
Vorinostat
EGFR
resistance
C797S
combination therapy
Vorinostat